×
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

Vascular Embolization Market Size

ID: MRFR/HC/10351-HCR
128 Pages
Kinjoll Dey
October 2025

Vascular Embolization Market Size, Growth Research Report By Embolization Technique (Coiling Devices and Non-coiling Devices), By Application (Peripheral Vascular Disease, Oncology, Neurology, Urology, and Other), and By Region (North America, Europe, Asia-Pacific, and Rest Of The World) – Competitor Industry Analysis and Trends Forecast Till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Vascular Embolization Market Infographic
Request Free Sample
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF

Vascular Embolization Size

Vascular Embolization Market Growth Projections and Opportunities

The market for vascular embolization is driven by many factors that work together to promote its growth and expansion. Among the major factors driving the market are rising incidence of vascular disorders and conditions. With the growing population worldwide, the number of aneurysms and diseases such as arteriovenous malformations also increase resulting to a high demand for vascular embolization procedures. On the other hand, this demand is met by embolic agents and devices that target a wide array of vascular defects. The growth in medical devices has been instrumental towards understanding the vascular embolization market. Constant innovation results in the rise of more advanced embolic products, delivery systems and imaging technology. Such innovations make vascular embolization procedures more precise, safe, and effective; this is why healthcare professionals have better opportunities to treat complex vascular disorders. The vascular embolization market landscape is shaped by the regulatory framework surrounding medical devices and interventional procedures. The specific regulatory standards guarantee the security, effectiveness, and quality of embolic agents along with devices that play some role in their acceptance for clinical use. The ability to comply with the regulatory requirements is one of the fundamental criteria for market entry and trust building among health care providers, patients’ population, and regulators. The socio-economic climate and health care infrastructure of various regions governs the implementation of vascular embolization procedures. Variations in health care access, reimbursement policies and economic conditions have an impact on embolization treatment prevalence. It is within these contrasting environments that market players must develop their products to meet the challenges provided by different healthcare systems. In vascular embolization market, the competitive landscape is dynamic with constant innovation and differentiation. Companies conduct research and development to develop embolic agents and devices with new features including specific delivery, less invasiveness, as well as visualization during procedures. This competitive landscape promotes an innovation cycle, where market participants sought to maintain technological leadership. The vascular embolization market has been affected by global health events like COVID-19. The pandemic resulted to elective medical procedures were disrupted meaning that the demand for vascular embolization was also impacted. Nevertheless, the enhanced adoption of embolization as a minimally invasive treatment method leads to market recovery and growth despite inevitable challenges for health care systems.

Vascular Embolization Market Size Graph
Author
Kinjoll Dey
Research Analyst Level I

He is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Kinjoll is comfortably versed in data centric research backed by healthcare educational background. He leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. His key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.

Get In Touch

Leave a Comment

FAQs

What is the current valuation of the Vascular Embolization Market as of 2024?

The Vascular Embolization Market was valued at 2.088 USD Billion in 2024.

What is the projected market size for the Vascular Embolization Market in 2035?

The market is projected to reach 5.9 USD Billion by 2035.

What is the expected CAGR for the Vascular Embolization Market during the forecast period 2025 - 2035?

The expected CAGR for the market during 2025 - 2035 is 9.9%.

Which companies are considered key players in the Vascular Embolization Market?

Key players include Medtronic, Boston Scientific, Terumo Corporation, and Johnson & Johnson, among others.

What are the main segments of the Vascular Embolization Market?

The main segments include Technique and Application, with specific categories like Coiling Devices and Oncology.

How did the Coiling Devices segment perform in 2024?

The Coiling Devices segment was valued at 0.835 USD Billion in 2024.

Market Summary

As per MRFR analysis, the Vascular Embolization Market was estimated at 2.088 USD Billion in 2024. The Vascular Embolization industry is projected to grow from 2.295 USD Billion in 2025 to 5.9 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 9.9 during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The Vascular Embolization Market is poised for substantial growth driven by technological advancements and increasing demand for minimally invasive procedures.

  • Technological advancements are enhancing the efficacy and safety of vascular embolization procedures.
  • North America remains the largest market, while Asia-Pacific is emerging as the fastest-growing region in this sector.
  • Coiling devices dominate the market, whereas non-coiling devices are witnessing rapid growth due to their innovative designs.
  • Key market drivers include the rising prevalence of vascular disorders and a growing preference for minimally invasive techniques.

Market Size & Forecast

2024 Market Size 2.088 (USD Billion)
2035 Market Size 5.9 (USD Billion)
CAGR (2025 - 2035) 9.9%
Largest Regional Market Share in 2024 North America

Major Players

<p>Medtronic (US), Boston Scientific (US), Terumo Corporation (JP), Johnson & Johnson (US), Stryker Corporation (US), Cook Medical (US), B. Braun Melsungen AG (DE), Abbott Laboratories (US), AngioDynamics (US)</p>

Market Trends

The Vascular Embolization Market is currently experiencing a notable transformation, driven by advancements in medical technology and an increasing prevalence of vascular diseases. As healthcare providers seek innovative solutions to manage conditions such as tumors and vascular malformations, the demand for embolization procedures is on the rise. This market appears to be influenced by a growing awareness of minimally invasive techniques, which offer patients reduced recovery times and lower risks compared to traditional surgical methods. Furthermore, the integration of advanced imaging technologies is enhancing the precision of these procedures, thereby improving patient outcomes and satisfaction. In addition, the Vascular Embolization Market is likely to benefit from ongoing research and development efforts aimed at creating new embolic agents and devices. These innovations may provide healthcare professionals with a broader range of options to tailor treatments to individual patient needs. Moreover, the increasing collaboration between medical device manufacturers and healthcare institutions suggests a trend towards more comprehensive care solutions. As the market evolves, it seems poised for sustained growth, reflecting the dynamic nature of the healthcare landscape and the continuous pursuit of improved therapeutic strategies.

Technological Advancements

The Vascular Embolization Market is witnessing a surge in technological innovations, particularly in the development of new embolic materials and delivery systems. These advancements are enhancing the efficacy and safety of embolization procedures, making them more appealing to both healthcare providers and patients.

Rising Incidence of Vascular Diseases

There is a growing prevalence of vascular diseases globally, which is driving the demand for embolization procedures. As more individuals are diagnosed with conditions requiring intervention, the Vascular Embolization Market is likely to expand to meet this increasing need.

Shift Towards Minimally Invasive Procedures

Healthcare professionals are increasingly favoring minimally invasive techniques over traditional surgical options. This shift is influencing the Vascular Embolization Market, as patients seek treatments that offer quicker recovery times and fewer complications.

Vascular Embolization Market Market Drivers

Increasing Prevalence of Vascular Disorders

The rising incidence of vascular disorders, such as arteriovenous malformations and uterine fibroids, is a significant driver for the Vascular Embolization Market. As populations age and lifestyle-related health issues become more common, the demand for effective treatment options is escalating. Recent statistics indicate that vascular diseases affect millions worldwide, leading to a heightened need for minimally invasive interventions. The Vascular Embolization Market is poised to benefit from this trend, as embolization procedures offer a less invasive alternative to traditional surgical methods. This shift not only improves patient recovery times but also reduces healthcare costs, further propelling market growth. The increasing awareness of vascular health and the importance of early intervention is likely to sustain this upward trajectory in the coming years.

Regulatory Support and Reimbursement Policies

Regulatory support and favorable reimbursement policies are pivotal factors influencing the Vascular Embolization Market. Governments and health authorities are increasingly recognizing the importance of embolization procedures in treating vascular conditions, leading to the establishment of supportive regulatory frameworks. Additionally, many insurance providers are expanding coverage for these minimally invasive treatments, which enhances patient access and encourages healthcare providers to adopt these techniques. The alignment of regulatory policies with clinical guidelines is likely to foster innovation and investment in the Vascular Embolization Market. As reimbursement models evolve to favor cost-effective and efficient treatments, the market is expected to experience sustained growth, driven by increased adoption of embolization procedures.

Rising Investment in Healthcare Infrastructure

Investment in healthcare infrastructure is a crucial driver for the Vascular Embolization Market. Governments and private entities are increasingly allocating resources to enhance medical facilities and expand access to advanced treatment options. This trend is particularly evident in emerging economies, where the establishment of specialized vascular centers is on the rise. Enhanced infrastructure not only facilitates the adoption of cutting-edge embolization technologies but also improves patient access to these services. As healthcare systems evolve, the Vascular Embolization Market is likely to benefit from increased patient volumes and a broader range of treatment offerings. The ongoing commitment to healthcare improvement suggests a promising outlook for the industry, with potential growth opportunities in various regions.

Technological Innovations in Vascular Embolization

The Vascular Embolization Market is experiencing a surge in technological innovations that enhance the efficacy and safety of procedures. Advanced imaging techniques, such as 3D angiography and real-time ultrasound, are becoming increasingly prevalent, allowing for more precise targeting of embolization agents. Furthermore, the development of novel embolic materials, including bioresorbable microspheres and liquid embolics, is expanding treatment options for clinicians. According to recent data, the market for embolization devices is projected to grow at a compound annual growth rate of approximately 6.5% over the next several years. This growth is indicative of the industry's response to the demand for improved patient outcomes and reduced procedural risks, thereby driving the overall expansion of the Vascular Embolization Market.

Growing Preference for Minimally Invasive Techniques

The Vascular Embolization Market is witnessing a marked shift towards minimally invasive techniques, which are favored by both patients and healthcare providers. These procedures typically result in shorter hospital stays, reduced pain, and quicker recovery times compared to conventional surgical approaches. As patients increasingly seek out options that minimize disruption to their daily lives, the demand for embolization procedures is expected to rise. Market analysis suggests that the minimally invasive segment is likely to capture a larger share of the overall vascular intervention market, with projections indicating a growth rate of around 7% annually. This trend reflects a broader movement within the healthcare sector towards patient-centered care, which is anticipated to further bolster the Vascular Embolization Market.

Market Segment Insights

By Technique: Coiling Devices (Largest) vs. Non-coiling Devices (Fastest-Growing)

<p>In the Vascular Embolization Market, coiling devices hold the largest market share due to their established efficacy in treating intracranial aneurysms and vascular lesions. These devices have been widely accepted by healthcare professionals, leading to significant preference over non-coiling methods in numerous procedures. Meanwhile, non-coiling devices are gaining traction, particularly among physicians looking for innovative, less invasive options, but currently occupy a smaller share of the market. The growth trends in this segment are largely driven by advancements in technology and the increasing prevalence of vascular diseases. Coiling devices continue to benefit from ongoing innovations that enhance their effectiveness and ease of use. Conversely, non-coiling devices are emerging as a fast-growing segment, fueled by rising demand for innovative procedures that reduce recovery times and potential complications, indicating a shift in treatment paradigms within the industry.</p>

<p>Technique: Coiling Devices (Dominant) vs. Non-coiling Devices (Emerging)</p>

<p>Coiling devices are characterized by their established presence in the Vascular Embolization Market and are primarily used for the treatment of aneurysms. Their market dominance stems from years of clinical success and widespread acceptance among medical professionals, resulting in high utilization rates. In contrast, non-coiling devices, which include various catheter-based options and new technologies, represent an emerging category aimed at fulfilling unmet clinical needs. These devices are designed to offer alternative solutions that minimize patient risks and enhance procedural efficiency, thereby attracting increasing interest from physicians seeking innovative treatment modalities. As the medical landscape evolves, these non-coiling options are expected to see accelerated adoption, driven by ongoing research and development.</p>

By Application: Peripheral Vascular Disease (Largest) vs. Oncology (Fastest-Growing)

<p>The Vascular Embolization Market exhibits a diverse range of application segments, with Peripheral Vascular Disease commanding a significant share due to the rising incidence of vascular disorders globally. Oncology follows closely behind, where tumor embolization procedures are gaining traction, thereby expanding its footprint in the market. Other segments such as Neurology and Urology, though smaller in comparison, still hold importance due to specific therapeutic needs in embolization treatments, resulting in a well-rounded distribution across various clinical applications. Growth trends within this segment are heavily influenced by technological advancements and increasing clinical indications for embolization. The increasing prevalence of chronic diseases, coupled with the rise in minimally invasive procedures, propels the demand for vascular interventions. Oncology is particularly witnessing accelerated growth as innovations in targeted therapies and embolization techniques enhance treatment outcomes. Furthermore, collaborative efforts among healthcare stakeholders strengthen market penetration, ensuring a robust future landscape for these applications.</p>

<p>Peripheral Vascular Disease (Dominant) vs. Oncology (Emerging)</p>

<p>Peripheral Vascular Disease stands out as the dominant application in the Vascular Embolization Market, characterized by a high volume of procedures related to limb ischemia and arterial blockages. Its established protocols and efficacy in managing chronic conditions solidify its leading status. On the other hand, Oncology is emerging rapidly, driven by a growing recognition of the role of embolization in treating various tumors. The evolution of skilled interventional radiology and the incorporation of advanced embolic agents highlight its potential. While Peripheral Vascular Disease benefits from a traditional patient base, Oncology is garnering interest due to increased research and successful clinical outcomes, positioning it as a key player in the future market.</p>

Get more detailed insights about Vascular Embolization Market Research Report—Global Forecast till 2035

Regional Insights

North America : Market Leader in Innovation

North America is the largest market for vascular embolization, holding approximately 45% of the global share. The region benefits from advanced healthcare infrastructure, high prevalence of vascular diseases, and significant investments in medical technology. Regulatory support from agencies like the FDA further drives innovation and adoption of new embolization techniques, enhancing market growth. The United States is the primary contributor, with key players such as Medtronic, Boston Scientific, and Johnson & Johnson leading the competitive landscape. The presence of established healthcare systems and a focus on minimally invasive procedures are pivotal in shaping market dynamics. The region's emphasis on research and development ensures a steady pipeline of innovative products, catering to the growing demand for effective vascular treatments.

Europe : Emerging Market with Growth Potential

Europe is witnessing significant growth in the vascular embolization market, accounting for approximately 30% of the global share. Factors such as an aging population, increasing awareness of vascular diseases, and supportive healthcare policies are driving demand. The European Medicines Agency (EMA) plays a crucial role in regulating and approving new embolization devices, fostering innovation in the sector. Leading countries include Germany, France, and the UK, where major players like B. Braun Melsungen AG and Terumo Corporation are actively involved. The competitive landscape is characterized by collaborations and partnerships aimed at enhancing product offerings. The region's focus on improving patient outcomes through advanced medical technologies is expected to further boost market growth in the coming years.

Asia-Pacific : Rapidly Growing Healthcare Sector

Asia-Pacific is emerging as a significant player in the vascular embolization market, holding around 20% of the global share. The region's growth is fueled by increasing healthcare expenditure, rising prevalence of chronic diseases, and a growing middle-class population. Government initiatives aimed at improving healthcare access and affordability are also contributing to market expansion. Countries like Japan, China, and India are at the forefront, with key players such as Terumo Corporation and Abbott Laboratories making substantial investments. The competitive landscape is evolving, with local manufacturers entering the market, enhancing competition. The region's focus on technological advancements and partnerships with global firms is expected to drive further growth in the vascular embolization sector.

Middle East and Africa : Untapped Market with Opportunities

The Middle East and Africa represent an untapped market for vascular embolization, accounting for approximately 5% of the global share. The region is characterized by a growing demand for advanced medical technologies, driven by increasing healthcare investments and a rising burden of vascular diseases. Regulatory bodies are gradually improving frameworks to facilitate the introduction of innovative embolization products. Countries like South Africa and the UAE are leading the way, with a focus on enhancing healthcare infrastructure. The competitive landscape is still developing, with opportunities for both local and international players. The presence of key companies like Cook Medical and AngioDynamics is expected to stimulate market growth, as they introduce new technologies tailored to regional needs.

Key Players and Competitive Insights

The Vascular Embolization Market is currently characterized by a dynamic competitive landscape, driven by technological advancements and an increasing prevalence of vascular diseases. Key players such as Medtronic (US), Boston Scientific (US), and Terumo Corporation (JP) are strategically positioned to leverage innovation and expand their market presence. Medtronic (US) focuses on enhancing its product portfolio through continuous research and development, while Boston Scientific (US) emphasizes strategic partnerships to bolster its market reach. Terumo Corporation (JP) is actively pursuing regional expansion, particularly in emerging markets, which collectively shapes a competitive environment that is both collaborative and competitive.

The market structure appears moderately fragmented, with several players vying for market share. Key business tactics include localizing manufacturing to reduce costs and optimize supply chains, which is essential in maintaining competitive pricing. The influence of major players is significant, as their operational strategies often set industry standards and drive innovation across the sector.

In August 2025, Medtronic (US) announced the launch of a new embolization device designed for minimally invasive procedures. This strategic move is likely to enhance their competitive edge by addressing the growing demand for less invasive treatment options, thereby appealing to both healthcare providers and patients. The introduction of this device may also reinforce Medtronic's commitment to innovation in the vascular space, potentially increasing its market share.

In September 2025, Boston Scientific (US) entered into a partnership with a leading telehealth provider to integrate digital solutions into its embolization products. This collaboration is indicative of a broader trend towards digital transformation in healthcare, suggesting that Boston Scientific is positioning itself to capitalize on the growing demand for remote patient monitoring and telemedicine solutions. Such initiatives may enhance patient outcomes and streamline operational efficiencies.

In July 2025, Terumo Corporation (JP) expanded its manufacturing capabilities in Southeast Asia, aiming to meet the rising demand for vascular embolization products in the region. This strategic expansion not only reflects Terumo's commitment to regional growth but also highlights the importance of supply chain optimization in a competitive market. By localizing production, Terumo may reduce lead times and improve responsiveness to market needs, thereby strengthening its competitive position.

As of October 2025, the Vascular Embolization Market is witnessing trends such as increased digitalization, sustainability initiatives, and the integration of artificial intelligence in product development. Strategic alliances are becoming increasingly vital, as companies seek to enhance their technological capabilities and market reach. The competitive differentiation is likely to evolve from traditional price-based competition towards a focus on innovation, advanced technology, and reliable supply chains, indicating a shift in how companies will compete in the future.

Key Companies in the Vascular Embolization Market market include

Industry Developments

  • Q2 2024: Boston Scientific Announces FDA Clearance of the EMBOLX™ Vascular Embolization Market System Boston Scientific received FDA clearance for its EMBOLX™ Vascular Embolization Market System, expanding its portfolio of minimally invasive solutions for the treatment of vascular conditions.
  • Q2 2024: Penumbra Launches New Embolization Microcatheter Platform in the United States Penumbra announced the commercial launch of its latest embolization microcatheter platform, designed to improve precision and safety in vascular embolization procedures.
  • Q2 2024: Terumo Receives CE Mark for New HydroCoil Embolization System Terumo Corporation received CE Mark approval for its HydroCoil Embolization System, enabling commercialization in the European Union for neurovascular and peripheral vascular embolization.
  • Q2 2024: Medtronic Announces Strategic Partnership with Siemens Healthineers to Advance Image-Guided Vascular Embolization Market Medtronic entered a strategic partnership with Siemens Healthineers to integrate advanced imaging technologies into Medtronic’s vascular embolization product line.
  • Q3 2024: Abbott Launches New Embolization Coil for Peripheral Vascular Disease Abbott Laboratories launched a new embolization coil specifically designed for the treatment of peripheral vascular disease, expanding its interventional product portfolio.
  • Q3 2024: Cook Medical Opens New Manufacturing Facility for Embolization Devices in Indiana Cook Medical inaugurated a new manufacturing facility in Indiana dedicated to the production of vascular embolization devices, aiming to meet growing global demand.
  • Q3 2024: Stryker Receives FDA Approval for Next-Generation Neurovascular Embolization Device Stryker Corporation received FDA approval for its next-generation neurovascular embolization device, designed to treat cerebral aneurysms with enhanced safety and efficacy.
  • Q4 2024: Merit Medical Systems Announces Acquisition of Embolization Technology Startup Merit Medical Systems acquired a startup specializing in novel embolization technologies, aiming to strengthen its position in the vascular intervention market.
  • Q4 2024: Cerenovus Launches New Liquid Embolic Agent for Neurovascular Applications Cerenovus, a Johnson & Johnson company, launched a new liquid embolic agent for neurovascular applications, targeting the treatment of arteriovenous malformations and aneurysms.
  • Q1 2025: Boston Scientific Expands Vascular Embolization Market Portfolio with Acquisition of European Device Maker Boston Scientific acquired a European vascular embolization device manufacturer, broadening its product offerings and strengthening its presence in the region.
  • Q1 2025: Penumbra Announces $100 Million Series D Funding to Accelerate Embolization Technology Development Penumbra raised $100 million in Series D funding to support research and development of next-generation vascular embolization technologies.
  • Q2 2025: Terumo Opens New R&D Center Focused on Vascular Embolization Market Innovations Terumo Corporation opened a new research and development center dedicated to advancing vascular embolization device technology and clinical applications.

Future Outlook

Vascular Embolization Market Future Outlook

<p>The Vascular Embolization Market is projected to grow at a 9.9% CAGR from 2024 to 2035, driven by technological advancements, increasing prevalence of vascular diseases, and rising healthcare expenditure.</p>

New opportunities lie in:

  • <p>Development of biodegradable embolic agents for enhanced patient safety.</p>
  • <p>Expansion of telemedicine platforms for remote embolization consultations.</p>
  • <p>Investment in AI-driven imaging technologies for improved procedural accuracy.</p>

<p>By 2035, the Vascular Embolization Market is expected to achieve substantial growth and innovation.</p>

Market Segmentation

Vascular Embolization Market Technique Outlook

  • Coiling Devices
  • Non-coiling Devices

Vascular Embolization Market Application Outlook

  • Peripheral Vascular Disease
  • Oncology
  • Neurology
  • Urology
  • Other

Report Scope

MARKET SIZE 20242.088(USD Billion)
MARKET SIZE 20252.295(USD Billion)
MARKET SIZE 20355.9(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)9.9% (2024 - 2035)
REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR2024
Market Forecast Period2025 - 2035
Historical Data2019 - 2024
Market Forecast UnitsUSD Billion
Key Companies ProfiledMarket analysis in progress
Segments CoveredMarket segmentation analysis in progress
Key Market OpportunitiesAdvancements in biocompatible materials enhance efficacy in the Vascular Embolization Market.
Key Market DynamicsTechnological advancements and regulatory changes drive innovation and competition in the vascular embolization market.
Countries CoveredNorth America, Europe, APAC, South America, MEA

FAQs

What is the current valuation of the Vascular Embolization Market as of 2024?

The Vascular Embolization Market was valued at 2.088 USD Billion in 2024.

What is the projected market size for the Vascular Embolization Market in 2035?

The market is projected to reach 5.9 USD Billion by 2035.

What is the expected CAGR for the Vascular Embolization Market during the forecast period 2025 - 2035?

The expected CAGR for the market during 2025 - 2035 is 9.9%.

Which companies are considered key players in the Vascular Embolization Market?

Key players include Medtronic, Boston Scientific, Terumo Corporation, and Johnson & Johnson, among others.

What are the main segments of the Vascular Embolization Market?

The main segments include Technique and Application, with specific categories like Coiling Devices and Oncology.

How did the Coiling Devices segment perform in 2024?

The Coiling Devices segment was valued at 0.835 USD Billion in 2024.

  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. EXECUTIVE SUMMARY
      1. Market Overview
      2. Key Findings
      3. Market Segmentation
      4. Competitive Landscape
      5. Challenges and Opportunities
      6. Future Outlook
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. MARKET INTRODUCTION
      1. Definition
      2. Scope of the study
    2. RESEARCH METHODOLOGY
      1. Overview
      2. Data Mining
      3. Secondary Research
      4. Primary Research
      5. Forecasting Model
      6. Market Size Estimation
      7. Data Triangulation
      8. Validation
  3. SECTION III: QUALITATIVE ANALYSIS
    1. MARKET DYNAMICS
      1. Overview
      2. Drivers
      3. Restraints
      4. Opportunities
    2. MARKET FACTOR ANALYSIS
      1. Value chain Analysis
      2. Porter's Five Forces Analysis
      3. COVID-19 Impact Analysis
  4. SECTION IV: QUANTITATIVE ANALYSIS
    1. Healthcare, BY Technique (USD Billion)
      1. Coiling Devices
      2. Non-coiling Devices
    2. Healthcare, BY Application (USD Billion)
      1. Peripheral Vascular Disease
      2. Oncology
      3. Neurology
      4. Urology
      5. Other
    3. Healthcare, BY Region (USD Billion)
      1. North America
      2. Europe
      3. APAC
      4. South America
      5. MEA
  5. SECTION V: COMPETITIVE ANALYSIS
    1. Competitive Landscape
      1. Overview
      2. Competitive Analysis
      3. Market share Analysis
      4. Major Growth Strategy in the Healthcare
      5. Competitive Benchmarking
      6. Leading Players in Terms of Number of Developments in the Healthcare
      7. Key developments and growth strategies
      8. Major Players Financial Matrix
    2. Company Profiles
      1. Medtronic (US)
      2. Boston Scientific (US)
      3. Terumo Corporation (JP)
      4. Johnson & Johnson (US)
      5. Stryker Corporation (US)
      6. Cook Medical (US)
      7. B. Braun Melsungen AG (DE)
      8. Abbott Laboratories (US)
      9. AngioDynamics (US)
    3. Appendix
      1. References
      2. Related Reports
  6. LIST OF FIGURES
    1. MARKET SYNOPSIS
    2. NORTH AMERICA MARKET ANALYSIS
    3. US MARKET ANALYSIS BY TECHNIQUE
    4. US MARKET ANALYSIS BY APPLICATION
    5. CANADA MARKET ANALYSIS BY TECHNIQUE
    6. CANADA MARKET ANALYSIS BY APPLICATION
    7. EUROPE MARKET ANALYSIS
    8. GERMANY MARKET ANALYSIS BY TECHNIQUE
    9. GERMANY MARKET ANALYSIS BY APPLICATION
    10. UK MARKET ANALYSIS BY TECHNIQUE
    11. UK MARKET ANALYSIS BY APPLICATION
    12. FRANCE MARKET ANALYSIS BY TECHNIQUE
    13. FRANCE MARKET ANALYSIS BY APPLICATION
    14. RUSSIA MARKET ANALYSIS BY TECHNIQUE
    15. RUSSIA MARKET ANALYSIS BY APPLICATION
    16. ITALY MARKET ANALYSIS BY TECHNIQUE
    17. ITALY MARKET ANALYSIS BY APPLICATION
    18. SPAIN MARKET ANALYSIS BY TECHNIQUE
    19. SPAIN MARKET ANALYSIS BY APPLICATION
    20. REST OF EUROPE MARKET ANALYSIS BY TECHNIQUE
    21. REST OF EUROPE MARKET ANALYSIS BY APPLICATION
    22. APAC MARKET ANALYSIS
    23. CHINA MARKET ANALYSIS BY TECHNIQUE
    24. CHINA MARKET ANALYSIS BY APPLICATION
    25. INDIA MARKET ANALYSIS BY TECHNIQUE
    26. INDIA MARKET ANALYSIS BY APPLICATION
    27. JAPAN MARKET ANALYSIS BY TECHNIQUE
    28. JAPAN MARKET ANALYSIS BY APPLICATION
    29. SOUTH KOREA MARKET ANALYSIS BY TECHNIQUE
    30. SOUTH KOREA MARKET ANALYSIS BY APPLICATION
    31. MALAYSIA MARKET ANALYSIS BY TECHNIQUE
    32. MALAYSIA MARKET ANALYSIS BY APPLICATION
    33. THAILAND MARKET ANALYSIS BY TECHNIQUE
    34. THAILAND MARKET ANALYSIS BY APPLICATION
    35. INDONESIA MARKET ANALYSIS BY TECHNIQUE
    36. INDONESIA MARKET ANALYSIS BY APPLICATION
    37. REST OF APAC MARKET ANALYSIS BY TECHNIQUE
    38. REST OF APAC MARKET ANALYSIS BY APPLICATION
    39. SOUTH AMERICA MARKET ANALYSIS
    40. BRAZIL MARKET ANALYSIS BY TECHNIQUE
    41. BRAZIL MARKET ANALYSIS BY APPLICATION
    42. MEXICO MARKET ANALYSIS BY TECHNIQUE
    43. MEXICO MARKET ANALYSIS BY APPLICATION
    44. ARGENTINA MARKET ANALYSIS BY TECHNIQUE
    45. ARGENTINA MARKET ANALYSIS BY APPLICATION
    46. REST OF SOUTH AMERICA MARKET ANALYSIS BY TECHNIQUE
    47. REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
    48. MEA MARKET ANALYSIS
    49. GCC COUNTRIES MARKET ANALYSIS BY TECHNIQUE
    50. GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
    51. SOUTH AFRICA MARKET ANALYSIS BY TECHNIQUE
    52. SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
    53. REST OF MEA MARKET ANALYSIS BY TECHNIQUE
    54. REST OF MEA MARKET ANALYSIS BY APPLICATION
    55. KEY BUYING CRITERIA OF HEALTHCARE
    56. RESEARCH PROCESS OF MRFR
    57. DRO ANALYSIS OF HEALTHCARE
    58. DRIVERS IMPACT ANALYSIS: HEALTHCARE
    59. RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    60. SUPPLY / VALUE CHAIN: HEALTHCARE
    61. HEALTHCARE, BY TECHNIQUE, 2024 (% SHARE)
    62. HEALTHCARE, BY TECHNIQUE, 2024 TO 2035 (USD Billion)
    63. HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
    64. HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
    65. BENCHMARKING OF MAJOR COMPETITORS
  7. LIST OF TABLES
    1. LIST OF ASSUMPTIONS
    2. North America MARKET SIZE ESTIMATES; FORECAST
      1. BY TECHNIQUE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
    3. US MARKET SIZE ESTIMATES; FORECAST
      1. BY TECHNIQUE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
    4. Canada MARKET SIZE ESTIMATES; FORECAST
      1. BY TECHNIQUE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
    5. Europe MARKET SIZE ESTIMATES; FORECAST
      1. BY TECHNIQUE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
    6. Germany MARKET SIZE ESTIMATES; FORECAST
      1. BY TECHNIQUE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
    7. UK MARKET SIZE ESTIMATES; FORECAST
      1. BY TECHNIQUE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
    8. France MARKET SIZE ESTIMATES; FORECAST
      1. BY TECHNIQUE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
    9. Russia MARKET SIZE ESTIMATES; FORECAST
      1. BY TECHNIQUE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
    10. Italy MARKET SIZE ESTIMATES; FORECAST
      1. BY TECHNIQUE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
    11. Spain MARKET SIZE ESTIMATES; FORECAST
      1. BY TECHNIQUE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
    12. Rest of Europe MARKET SIZE ESTIMATES; FORECAST
      1. BY TECHNIQUE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
    13. APAC MARKET SIZE ESTIMATES; FORECAST
      1. BY TECHNIQUE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
    14. China MARKET SIZE ESTIMATES; FORECAST
      1. BY TECHNIQUE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
    15. India MARKET SIZE ESTIMATES; FORECAST
      1. BY TECHNIQUE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
    16. Japan MARKET SIZE ESTIMATES; FORECAST
      1. BY TECHNIQUE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
    17. South Korea MARKET SIZE ESTIMATES; FORECAST
      1. BY TECHNIQUE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
    18. Malaysia MARKET SIZE ESTIMATES; FORECAST
      1. BY TECHNIQUE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
    19. Thailand MARKET SIZE ESTIMATES; FORECAST
      1. BY TECHNIQUE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
    20. Indonesia MARKET SIZE ESTIMATES; FORECAST
      1. BY TECHNIQUE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
    21. Rest of APAC MARKET SIZE ESTIMATES; FORECAST
      1. BY TECHNIQUE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
    22. South America MARKET SIZE ESTIMATES; FORECAST
      1. BY TECHNIQUE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
    23. Brazil MARKET SIZE ESTIMATES; FORECAST
      1. BY TECHNIQUE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
    24. Mexico MARKET SIZE ESTIMATES; FORECAST
      1. BY TECHNIQUE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
    25. Argentina MARKET SIZE ESTIMATES; FORECAST
      1. BY TECHNIQUE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
    26. Rest of South America MARKET SIZE ESTIMATES; FORECAST
      1. BY TECHNIQUE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
    27. MEA MARKET SIZE ESTIMATES; FORECAST
      1. BY TECHNIQUE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
    28. GCC Countries MARKET SIZE ESTIMATES; FORECAST
      1. BY TECHNIQUE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
    29. South Africa MARKET SIZE ESTIMATES; FORECAST
      1. BY TECHNIQUE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
    30. Rest of MEA MARKET SIZE ESTIMATES; FORECAST
      1. BY TECHNIQUE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
    31. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    32. ACQUISITION/PARTNERSHIP

Vascular Embolization Market Segmentation

Vascular Embolization Embolization Technique Outlook (USD Billion, 2018-2032)

  • Coiling Devices
  • Non-coiling Devices

Vascular Embolization Application Outlook (USD Billion, 2018-2032)

  • Peripheral Vascular Disease
  • Oncology
  • Neurology
  • Urology
  • Other

Vascular Embolization Regional Outlook (USD Billion, 2018-2032)

  • North America Outlook (USD Billion, 2018-2032)

    • Vascular Embolization by Embolization Technique
      • Coiling Devices
      • Non-coiling Devices
    • Vascular Embolization by Application
      • Peripheral Vascular Disease
      • Oncology
      • Neurology
      • Urology
      • Other

    • US Outlook (USD Billion, 2018-2032)

    • Vascular Embolization by Embolization Technique
      • Coiling Devices
      • Non-coiling Devices
    • Vascular Embolization by Application
      • Peripheral Vascular Disease
      • Oncology
      • Neurology
      • Urology
      • Other

    • Canada Outlook (USD Billion, 2018-2032)

    • Vascular Embolization by Embolization Technique
      • Coiling Devices
      • Non-coiling Devices
    • Vascular Embolization by Application
      • Peripheral Vascular Disease
      • Oncology
      • Neurology
      • Urology
      • Other

  • Europe Outlook (USD Billion, 2018-2032)

    • Vascular Embolization by Embolization Technique
      • Coiling Devices
      • Non-coiling Devices
    • Vascular Embolization by Application
      • Peripheral Vascular Disease
      • Oncology
      • Neurology
      • Urology
      • Other

    • Germany Outlook (USD Billion, 2018-2032)

    • Vascular Embolization by Embolization Technique
      • Coiling Devices
      • Non-coiling Devices
    • Vascular Embolization by Application
      • Peripheral Vascular Disease
      • Oncology
      • Neurology
      • Urology
      • Other

    • France Outlook (USD Billion, 2018-2032)

    • Vascular Embolization by Embolization Technique
      • Coiling Devices
      • Non-coiling Devices
    • Vascular Embolization by Application
      • Peripheral Vascular Disease
      • Oncology
      • Neurology
      • Urology
      • Other

    • UK Outlook (USD Billion, 2018-2032)

    • Vascular Embolization by Embolization Technique
      • Coiling Devices
      • Non-coiling Devices
    • Vascular Embolization by Application
      • Peripheral Vascular Disease
      • Oncology
      • Neurology
      • Urology
      • Other

    • Italy Outlook (USD Billion, 2018-2032)

    • Vascular Embolization by Embolization Technique
      • Coiling Devices
      • Non-coiling Devices
    • Vascular Embolization by Application
      • Peripheral Vascular Disease
      • Oncology
      • Neurology
      • Urology
      • Other

    • Spain Outlook (USD Billion, 2018-2032)

    • Vascular Embolization by Embolization Technique
      • Coiling Devices
      • Non-coiling Devices
    • Vascular Embolization by Application
      • Peripheral Vascular Disease
      • Oncology
      • Neurology
      • Urology
      • Other

    • Rest Of Europe Outlook (USD Billion, 2018-2032)

    • Vascular Embolization by Embolization Technique
      • Coiling Devices
      • Non-coiling Devices
    • Vascular Embolization by Application
      • Peripheral Vascular Disease
      • Oncology
      • Neurology
      • Urology
      • Other

  • Asia-Pacific Outlook (USD Billion, 2018-2032)

    • Vascular Embolization by Embolization Technique
      • Coiling Devices
      • Non-coiling Devices
    • Vascular Embolization by Application
      • Peripheral Vascular Disease
      • Oncology
      • Neurology
      • Urology
      • Other

    • China Outlook (USD Billion, 2018-2032)

    • Vascular Embolization by Embolization Technique
      • Coiling Devices
      • Non-coiling Devices
    • Vascular Embolization by Application
      • Peripheral Vascular Disease
      • Oncology
      • Neurology
      • Urology
      • Other

    • Japan Outlook (USD Billion, 2018-2032)

    • Vascular Embolization by Embolization Technique
      • Coiling Devices
      • Non-coiling Devices
    • Vascular Embolization by Application
      • Peripheral Vascular Disease
      • Oncology
      • Neurology
      • Urology
      • Other

    • India Outlook (USD Billion, 2018-2032)

    • Vascular Embolization by Embolization Technique
      • Coiling Devices
      • Non-coiling Devices
    • Vascular Embolization by Application
      • Peripheral Vascular Disease
      • Oncology
      • Neurology
      • Urology
      • Other

    • Australia Outlook (USD Billion, 2018-2032)

    • Vascular Embolization by Embolization Technique
      • Coiling Devices
      • Non-coiling Devices
    • Vascular Embolization by Application
      • Peripheral Vascular Disease
      • Oncology
      • Neurology
      • Urology
      • Other

    • Rest of Asia-Pacific Outlook (USD Billion, 2018-2032)

    • Vascular Embolization by Embolization Technique
      • Coiling Devices
      • Non-coiling Devices
    • Vascular Embolization by Application
      • Peripheral Vascular Disease
      • Oncology
      • Neurology
      • Urology
      • Other

  • Rest of the World Outlook (USD Billion, 2018-2032)

    • Vascular Embolization by Embolization Technique
      • Coiling Devices
      • Non-coiling Devices
    • Vascular Embolization by Application
      • Peripheral Vascular Disease
      • Oncology
      • Neurology
      • Urology
      • Other

    • Middle East Outlook (USD Billion, 2018-2032)

    • Vascular Embolization by Embolization Technique
      • Coiling Devices
      • Non-coiling Devices
    • Vascular Embolization by Application
      • Peripheral Vascular Disease
      • Oncology
      • Neurology
      • Urology
      • Other

    • Africa Outlook (USD Billion, 2018-2032)

    • Vascular Embolization by Embolization Technique
      • Coiling Devices
      • Non-coiling Devices
    • Vascular Embolization by Application
      • Peripheral Vascular Disease
      • Oncology
      • Neurology
      • Urology
      • Other

    • Latin America Outlook (USD Billion, 2018-2032)

    • Vascular Embolization by Embolization Technique
      • Coiling Devices
      • Non-coiling Devices
    • Vascular Embolization by Application
      • Peripheral Vascular Disease
      • Oncology
      • Neurology
      • Urology
      • Other
Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Related Reports

Regional Reports
Country Reports

Customer Strories

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Victoria Milne

Founder
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓